FDA cleared advantage DARI Motion offers the world’s only validated and FDA cleared 3D motion analysis solution that operates without markers. This differentiator can be leveraged to target large teams and organizations seeking efficient, noninvasive biomechanics tooling for injury prevention and performance optimization.

Rapid scalable analytics With a patented technology and a user-friendly, marker-free workflow, emphasize quick, repeatable full-body assessments. This can translate into high-volume adoption in sports teams, clinics, and corporate wellness programs looking to scale musculoskeletal health analytics.

Strategic partnerships DARI Motion highlights key partnerships as a path to market; position partnerships as a channel to accelerate deployment in healthcare, sports performance, and research institutions, expanding reach beyond direct sales to integrator-driven opportunities.

Large biometric dataset Access to the world’s largest biomechanical database (over 400 billion data points) can be sold as a data-enabled value proposition for enterprise clients needing benchmarks, benchmarking tools, or advanced analytics to inform injury prevention strategies and product development.

Mid-market growth potential Revenue range and employee size indicate a niche, high-potential B2B target. Focus on mid-market sports teams, clinics, and research labs that require scalable, cost-effective motion analysis without the burden of sensors or markers.